Cited by 271Gastrointestinal motility and disordersGut microbiota and healthInflammatory Bowel Disease

The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

Open access

Xu, Dabo, Gao, Jun, Gillilland, Merritt, Wu, Xiaoyin, Song, Il, Kao, John Y., Owyang, Chung·2014·Gastroenterology

DOI 10.1053/j.gastro.2013.10.026PMC PMC3939606

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Rifaximin is used to treat patients with functional gastrointestinal disorders, but little is known about its therapeutic mechanism. We propose that rifaximin modulates the ileal bacterial community, reduces subclinical inflammation of the intestinal mucosa, and improves gut barrier function to reduce visceral hypersensitivity.Methods We induced visceral hyperalgesia in rats, via chronic water avoidance or repeat restraint stressors, and investigated whether rifaximin altered the gut microbiota, prevented intestinal inflammation, and improved gut barrier function. Quantitative polymerase chain reaction (PCR) and 454 pyrosequencing were used to analyze bacterial 16S ribosomal RNA in ileal contents from the rats. Reverse transcription, immunoblot, and histologic analyses were used to evaluate levels of cytokines, the tight junction protein occludin, and mucosal inflammation, respectively. Intestinal permeability and rectal sensitivity were measured.Results Water avoidance and repeat restraint stress each led to visceral hyperalgesia, accompanied by mucosal inflammation and impaired mucosal barrier function. Oral rifaximin altered the composition of bacterial communities in the ileum (Lactobacillus species became the most abundant) and prevented mucosal inflammation, impairment to intestinal barrier function, and visceral hyperalgesia in response to chronic stress. Neomycin also changed the composition of the ileal bacterial community (Proteobacteria became the most abundant species). Neomycin did not prevent intestinal inflammation or induction of visceral hyperalgesia induced by water avoidance stress.Conclusions Rifaximin alters the bacterial population in the ileum of rats, leading to a relative abundance of Lactobacillus. These changes prevent intestinal abnormalities and visceral hyperalgesia in response to chronic psychological stress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2013.10.026

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
Bailey, M. T., Dowd, S. E., Galley, J. D., Hufnagle, A. R., Allen, R. G., & Lyte, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.023 · Cited by 1,123
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses
O'Mahony, S. M., Marchesi, J. R., Scully, P., Codling, C., Ceolho, A.-M., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.026 · Cited by 1,069
Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome
Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Intestinal barrier function in health and gastrointestinal disease
Camilleri, M., Madsen, K., Spiller, R., Van Meerveld, B. G., & Verne, G. N. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01921.x · Cited by 908
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 880
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
Jeffery, I. B., O'Toole, P. W., Öhman, L., Claesson, M. J., Deane, J., Quigley, E. M. M., & Simrén, M. (2012) · Gut · doi:10.1136/gutjnl-2011-301501 · Cited by 835

Show all 47 references

Research works printed but not linked: 4

Zelena, 2003, Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint, Am J Physiol Endocrinol Metab, 285, E1110, 10.1152/ajpendo.00219.2003 · DOI
Schloss, 2009, Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities, Appl Environ Microbiol, 75, 7537, 10.1128/AEM.01541-09 · DOI · Paper page
Coutinho, 2002, Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat, Am J Physiol Gastrointest Liver Physiol, 282, G307, 10.1152/ajpgi.00240.2001 · DOI
Bradesi, 2005, Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia, Am J Physiol Gastrointest Liver Physiol, 289, G42, 10.1152/ajpgi.00500.2004 · DOI

Sorted by citations

Pathophysiology of irritable bowel syndrome
Holtmann, G. J., Ford, A. C., & Talley, N. J. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30023-1 · Cited by 590
Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota
Karl, J. P., Hatch‐McChesney, A., Arcidiacono, S. M., Pearce, S., Pantoja-Feliciano, I. G., Doherty, L. A., & Soares, J. W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02013 · Cited by 563
Brain gut microbiome interactions and functional bowel disorders
Mayer, E. A., Savidge, T., & Shulman, R. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.037 · Cited by 496
Application of metagenomics in the human gut microbiome
Wang, W., Xu, S., Ren, Z., Tao, L., Jiang, J., & Zheng, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i3.803 · Cited by 419
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Kennedy, P. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14105 · Cited by 347
Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression
Luna, R. A., & Foster, J. A. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.007 · Cited by 325
Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression
Liu, Y., Zhang, L., Wang, X., Wang, Z., Zhang, J., Jiang, R., Wang, X., Wang, K., Liu, Z., Xia, Z., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.033 · Cited by 301
Self-citation
Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats
O’Mahony, S. M., Felice, V. D., Nally, K., Savignac, H. M., Claesson, M. J., Scully, P., Woznicki, J., Hyland, N. P., Shanahan, F., Quigley, E. M., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.054 · Cited by 272
The microbiota in cirrhosis and its role in hepatic decompensation
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 283
Microbiome as a therapeutic target in alcohol-related liver disease
Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 254
Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat
Li, H., Xiang, Y., Zhu, Z., Wang, W., Jiang, Z., Zhao, M., Cheng, S., Pan, F., Liu, D., Ho, R., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02303-y · Cited by 258
Antimicrobial growth promoter use in livestock: a requirement to understand their modes of action to develop effective alternatives
Brown, K., Uwiera, R. R. E., Kalmokoff, M. L., Brooks, S., & Inglis, G. D. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.006 · Cited by 245
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Patel, V., Lee, S., McPhail, M. J. W., Silva, K. D., Guilly, S., Zamalloa, A., Witherden, E. A., Støy, S. H., Vijay, G. K. M., Pons, N., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.010 · Cited by 240
The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study
Kurokawa, S., Kishimoto, T., Mizuno, S., Masaoka, T., Naganuma, M., Liang, K.-C., Kitazawa, M., Nakashima, M., Shindo, C., Suda, W., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.038 · Cited by 205
FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction
Zhou, S.-Y., Gillilland, M. G., Wu, X., Leelasinjaroen, P., Zhang, G., Zhou, H. R., Ye, B., Lu, Y., & Owyang, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92390 · Cited by 215
Self-citation
Gut Microbiota: The Brain Peacekeeper
Mu, C., Yang, Y., & Zhu, W. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00345 · Cited by 188
Role of the Gut–Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota–gut–brain axis perspective
Leigh, S., Uhlig, F., Wilmes, L., Sánchez-Díaz, P., Gheorghe, C. E., Goodson, M. S., Kelley‐Loughnane, N., Hyland, N. P., Cryan, J. F., & Clarke, G. A. (2023) · The Journal of Physiology · doi:10.1113/jp281951 · Cited by 201
Stress triggers flare of inflammatory bowel disease in children and adults
Sun, Y., Li, L., Xie, R., Wang, B., Jiang, K., & Cao, H. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00432 · Cited by 171
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets
DuPont, H. L. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12728 · Cited by 171
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
Ponziani, F. R., Zocco, M. A., D’Aversa, F., Pompili, M., & Gasbarrini, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4491 · Cited by 177
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice
Aguilera, M., Cerdà-Cuéllar, M., & Martínez, V (2015) · Gut Microbes · doi:10.4161/19490976.2014.990790 · Cited by 162
Stress-Induced Visceral Pain: Toward Animal Models of Irritable-Bowel Syndrome and Associated Comorbidities
Moloney, R. D., O’Mahony, S. M., Dinan, T. G., & Cryan, J. F. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00015 · Cited by 171
Bifidobacterium longum 1714™ Strain Modulates Brain Activity of Healthy Volunteers During Social Stress
Wang, H., Braun, C., Murphy, E. F., & Enck, P. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000203 · Cited by 159
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Forsythe, P., Kunze, W., & Bienenstock, J. (2016) · BMC Medicine · doi:10.1186/s12916-016-0604-8 · Cited by 162
The effect of gut microbiome on tolerance to morphine mediated antinociception in mice
Kang, M., Mischel, R. A., Bhave, S., Komla, E., Cho, A., Huang, C., Dewey, W. L., & Akbarali, H. I. (2017) · Scientific Reports · doi:10.1038/srep42658 · Cited by 154
Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia
Tan, V. P. Y., Liu, K. S. H., Lam, F. Y. F., Hung, I. F. N., Yuen, M. F., & Leung, W. K. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13945 · Cited by 143
New treatments and therapeutic targets for IBS and other functional bowel disorders
Simrén, M., & Tack, J. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0034-5 · Cited by 150
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin
Ponziani, F. R., Scaldaferri, F., Petito, V., Sterbini, F. P., Pecere, S., Lopetuso, L. R., Palladini, A., Gerardi, V., Masucci, L., Pompili, M., et al. (2016) · Digestive Diseases · doi:10.1159/000443361 · Cited by 138
An in vitro model maintaining taxon-specific functional activities of the gut microbiome
Li, L., Abou-Samra, E., Ning, Z., Zhang, X., Mayne, J., Wang, J., Cheng, K., Walker, K., Stintzi, A., & Figeys, D. (2019) · Nature Communications · doi:10.1038/s41467-019-12087-8 · Cited by 135
Metagenomic Assembly: Overview, Challenges and Applications.
Ghurye, J., Cepeda-Espinoza, V. P., & Pop, M. (2016) · PubMed Central · Cited by 131
Refractory Gastroesophageal Reflux Disease: A Management Update
Rettura, F., Bronzini, F., Campigotto, M., Lambiase, C., Pancetti, A., Berti, G., Marchi, S., de Bortoli, N., Zerbib, F., Savarino, E. V., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.765061 · Cited by 123
The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor
Galley, J. D., Yu, Z., Kumar, P., Dowd, S. E., Lyte, M., & Bailey, M. T. (2014) · Gut Microbes · doi:10.4161/19490976.2014.972241 · Cited by 124
Rifaximin: beyond the traditional antibiotic activity
Calanni, F., Renzulli, C., Barbanti, M., & Viscomi, G. C. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.106 · Cited by 119
Gut Microbiota-Derived Propionate Regulates the Expression of Reg3 Mucosal Lectins and Ameliorates Experimental Colitis in Mice
Bajic, D., Niemann, A., Hillmer, A.-K., Mejías‐Luque, R., Bluemel, S., Docampo, M. D., Funk, M. C., Tonin, E., Boutros, M., Schnabl, B., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa065 · Cited by 118
The Psychobiology of Bereavement and Health: A Conceptual Review From the Perspective of Social Signal Transduction Theory of Depression
Seiler, A., von Känel, R., & Slavich, G. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.565239 · Cited by 119
DHA-phospholipids (DHA-PL) and EPA-phospholipids (EPA-PL) prevent intestinal dysfunction induced by chronic stress
Cao, W., Wang, C., Chin, Y., Chen, X., Gao, Y., Yuan, S., Xue, C., Wang, Y., & Tang, Q. (2018) · Food & Function · doi:10.1039/c8fo01404c · Cited by 104
The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
Lin, H., Guo, Q., Wen, Z., Tan, S., Chen, J., Lin, L., Chen, P., He, J., Wen, J., & Chen, Y. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01720-1 · Cited by 103
Antibiotic growth promoter olaquindox increases pathogen susceptibility in fish by inducing gut microbiota dysbiosis
He, S., Wang, Q., Li, S., Ran, C., Guo, X., Zhang, Z., & Zhou, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9072-6 · Cited by 105
Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin
Meerveld, B. G., & Johnson, A. C. (2017) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2017.00086 · Cited by 102
Microbiome therapeutics for hepatic encephalopathy
Bloom, P. P., Tapper, E. B., Young, V. B., & Lok, A. S.-F. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.08.004 · Cited by 96
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Kang, D. J., Kakiyama, G., Betrapally, N. S., Herzog, J., Nittono, H., Hylemon, P. B., Zhou, H., Carroll, I. M., Yang, J., Gillevet, P. M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.44 · Cited by 97
A comparative and functional genomics analysis of the genus Romboutsia provides insight into adaptation to an intestinal lifestylePreprint
Gerritsen, J., Hornung, B., Ritari, J., Paulin, L. G., Rijkers, G. T., Schaap, P. J., de Vos, W. M., & Smidt, H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/845511 · Cited by 97
Probiotic, Prebiotic, and Brain Development
Cerdó, T., Ruiz-Rodriguez, A., Suárez, A., & Campoy, C. (2017) · Nutrients · doi:10.3390/nu9111247 · Cited by 103
Gut microbiota and allogeneic transplantation
Wang, W., Xu, S., Ren, Z., Jiang, J., & Zheng, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0640-8 · Cited by 92
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
Ponziani, F. R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12322 · Cited by 90
Association between Psychosocial Stress and Fecal Microbiota in Pregnant Women
Hechler, C., Borewicz, K., Beijers, R., Saccenti, E., Riksen-Walraven, M., Smidt, H., & de Weerth, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-40434-8 · Cited by 93
Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice
Yisireyili, M., Uchida, Y., Yamamoto, K., Nakayama, T., Cheng, X. W., Matsushita, T., Nakamura, S., Murohara, T., & Takeshita, K. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.010 · Cited by 85
Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
Fodor, A. A., Pimentel, M., Chey, W. D., Lembo, A. J., Golden, P. L., Israel, R. J., & Carroll, I. M. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1460013 · Cited by 84
Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
Rezaie, A. R., Heimanson, Z., McCallum, R. W., & Pimentel, M. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000444 · Cited by 84
Chronic Unpredictable Mild Stress in Rats Induces Colonic Inflammation
Wei, L., Li, Y., Tang, W., Sun, Q., Chen, L., Wang, X., Liu, Q., Yu, S., Yu, S., Liu, C., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01228 · Cited by 83
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome
Jin, D., Cao, H., Xu, M., Wang, S.-N., Wang, Y., Yan, F., & Wang, B. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i36.8137 · Cited by 82
Low-dose penicillin exposure in early life decreases Th17 and the susceptibility to DSS colitis in mice through gut microbiota modification
Jin, S., Zhao, D., Cai, C., Song, D., Shen, J., Xu, A., Qiao, Y., Ran, Z., & Zheng, Q. (2017) · Scientific Reports · doi:10.1038/srep43662 · Cited by 80
The joint power of sex and stress to modulate brain–gut–microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome
Pigrau, M., Rodiño‐Janeiro, B. K., Casado‐Bedmar, M., Lobo, B., Vicario, M., Santos, J., & Alonso, C. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12717 · Cited by 83
Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea
Pimentel, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13437 · Cited by 76
The gut microbiome in disorders of gut–brain interaction
Kraïmi, N., Ross, T., Pujo, J., & Palma, G. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2360233 · Cited by 93
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome
Żeber‐Lubecka, N., Kulecka, M., Ambrożkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., Rubel, T., Wojtowicz, W., Młynarz, P., Marczak, Ł., et al. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1215805 · Cited by 77
Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges
Meerveld, B. G., Prusator, D. K., & Johnson, A. C. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00463.2014 · Cited by 77
Review article: the antimicrobial effects of rifaximin on the gut microbiota
DuPont, H. L. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13434 · Cited by 78
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation
Zhang, J., Liu, J., Zhu, S., Fang, Y., Wang, B., Jia, Q., Hao, H., Kao, J. Y., He, Q., Song, L., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00601-4 · Cited by 75
Self-citation
Growth promotion and gut microbiota: insights from antibiotic use
Brüssow, H. (2015) · Environmental Microbiology · doi:10.1111/1462-2920.12786 · Cited by 70
Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center
Miwa, H., Oshima, T., Tomita, T., Fukui, H., Kondo, T., Yamasaki, T., & Watari, J. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01550-4 · Cited by 70
Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans
Scarpignato, C., Dolak, W., Lanas, Á., Matzneller, P., Renzulli, C., Grimaldi, M., Zeitlinger, M. A., & Bjarnason, I. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.12.007 · Cited by 68
The Link between Gut Microbiota and Hepatic Encephalopathy
Won, S., Oh, K., Gupta, H., Ganesan, R., Sharma, S. P., Jeong, J., Yoon, S. J., Jeong, M. K., Min, B. H., Hyun, J. Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168999 · Cited by 69
Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor‐mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human
Zong, Y., Zhu, S., Zhang, S., Zheng, G., Wiley, J. W., & Hong, S. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13477 · Cited by 71
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
Ludidi, S., Mujagic, Z., Jonkers, D. M. A. E., Keszthelyi, D., Hesselink, M., Kruimel, J. W., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12365 · Cited by 66
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial
Kimer, N., Pedersen, J. S., Tavenier, J., Christensen, J. E., Busk, T. M., Hobolth, L., Krag, A. A., Al‐Soud, W. A., Mortensen, M. S., Sørensen, S. J., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13852 · Cited by 69
Randomised clinical trial: Tong‐Xie‐Yao‐Fang granules versus placebo for patients with diarrhoea‐predominant irritable bowel syndrome
Chen, M., Tang, T., Wang, Y., Shui, J., Xiao, X.-H., Lan, X., Yu, P., Zhang, C., Wang, S.-H., Yao, J., et al. (2018) · Alimentary Pharmacology and Therapeutics · doi:10.1111/apt.14817 · Cited by 62
Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk
Baritaki, S., de Bree, E., Chatzaki, Ε., & Pothoulakis, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101669 · Cited by 67
Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
Yang, L., Liu, B., Zheng, J., Huang, J., Zhao, Q., Liu, J., Su, Z., Wang, M., Cui, Z., Wang, T., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00044 · Cited by 64
The microbiome and disorders of the central nervous system
Felice, V. D., & O'Mahony, S. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.016 · Cited by 60
Functional Dyspepsia: A Narrative Review With a Focus on Sex-Gender Differences
Kim, Y. S., & Kim, N. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20026 · Cited by 69
Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats
Terán-Ventura, E., Aguilera, M., Vergara, P., & Martínez, V. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.02.001 · Cited by 59
Carrion's Disease: the Sound of Silence
Gomes, C., & Ruiz, J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-17 · Cited by 58
Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review
Chey, W. D., Shah, E. D., & DuPont, H. L. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819897531 · Cited by 57
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea
Brenner, D. M., & Sayuk, G. S. (2020) · Advances in Therapy · doi:10.1007/s12325-019-01116-z · Cited by 55
Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling
Yoshikawa, K., Kurihara, C., Furuhashi, H., Takajo, T., Maruta, K., Yasutake, Y., Sato, H., Narimatsu, K., Okada, Y., Higashiyama, M., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1205-1 · Cited by 60
Gastrointestinal (non-systemic) antibiotic rifaximin differentially affects chronic stress-induced changes in colon microbiome and gut permeability without effect on behavior
Kuti, D., Winkler, Z., Horváth, K., Juhász, B., Paholcsek, M., Stágel, A., Gulyás, G., Czeglédi, L., Ferenczi, S., & Kovács, K. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.004 · Cited by 55
Loss of Gut Barrier Integrity In Lupus
Ma, L., & Morel, L. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919792 · Cited by 55
Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention
Colucci, R., Pellegrini, C., Fornai, M., Tirotta, E., Antonioli, L., Renzulli, C., Ghelardi, E., Piccoli, E., Gentile, D., Benvenuti, L., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01340 · Cited by 53
Beneficial effects of Rifaximin in post‐infectious irritable bowel syndrome mouse model beyond gut microbiota
Jin, Y. T., Ren, X., Li, G., Li, Y., Zhang, L., Wang, H., Qian, W., & Hou, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13841 · Cited by 52
Cyanidin-3- O -glucoside and its phenolic metabolites ameliorate intestinal diseases via modulating intestinal mucosal immune system: potential mechanisms and therapeutic strategies
Cheng, Z., Si, X., Tan, H., Zang, Z., Tian, J., Shu, C., Sun, X., Li, Z., Jiang, Q., Meng, X., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1966381 · Cited by 52
Immune responses in the irritable bowel syndromes: time to consider the small intestine
Burns, G. L., Talley, N. J., & Keely, S. (2022) · BMC Medicine · doi:10.1186/s12916-022-02301-8 · Cited by 54
Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study
Cobbold, J., Atkinson, S. R., Marchesi, J. R., Smith, A., Wai, S. N., Stove, J., Shojaee‐Moradie, F., Jackson, N., Umpleby, A. M., Fitzpatrick, J. A., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12904 · Cited by 50
Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model
Chen, B., Du, L., He, H., Kim, J. J., Zhao, Y. S., Zhang, Y., Luo, L., & Dai, N. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8321 · Cited by 49
Romboutsia hominis sp. nov., the first human gut-derived representative of the genus Romboutsia, isolated from ileostoma effluent
Gerritsen, J., Umanets, A., Staneva, I., Hornung, B., Ritari, J., Paulin, L. G., Rijkers, G. T., de Vos, W. M., & Smidt, H. (2018) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003012 · Cited by 50
Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome
Li, Y., Hong, G., Yang, M. J., Li, G., Jin, Y. T., Xiong, H., Qian, W., & Hou, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104936 · Cited by 49
Present and Future Therapeutic Approaches to Barrier Dysfunction
Fortea, M., Albert-Bayo, M., Abril-Gil, M., Mall, J. G., Serra-Ruiz, X., Henao-Paez, A., Expósito, E., González-Castro, A. M., Guagnozzi, D., Lobo, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718093 · Cited by 49
Probiotics: Comprehensive Exploration of the Growth Promotion Mechanisms in Shrimps
Goh, J. X. H., Tan, L. T., Law, J. W., Khaw, K. Y., Zengin, G., Chan, K., Letchumanan, V., Lee, L., & Goh, B. H. (2023) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000324 · Cited by 50
Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
Stern, E., & Brenner, D. M. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2018.2 · Cited by 50
Subacute stress and chronic stress interact to decrease intestinal barrier function in rats
Lauffer, A., Vanuytsel, T., Vanormelingen, C., Vanheel, H., Rasoel, S. S., Tóth, J. G., Tack, J. F., Fornari, F., & Farré, R. (2016) · Stress · doi:10.3109/10253890.2016.1154527 · Cited by 47
Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
Jian, J., Nie, M., Xiang, B., Qian, H., Yin, C., Zhang, X., Zhang, M. H., Zhu, X., & Xie, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841132 · Cited by 49
Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome?
Bai, T., Li, Y., Xia, J., Jiang, Y., Zhang, L., Wang, H., Qian, W., Song, J., & Hou, X. (2017) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16114 · Cited by 48
Evaluating in Vitro Culture Medium of Gut Microbiome with Orthogonal Experimental Design and a Metaproteomics Approach
Li, L., Zhang, X., Ning, Z., Mayne, J., Moore, J. I., Butcher, J., Chiang, C., Mack, D. R., Stintzi, A., & Figeys, D. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00461 · Cited by 46
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Colomier, E., Algera, J. P., & Melchior, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.629026 · Cited by 51
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists
Foxx–Orenstein, A. E. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16633050 · Cited by 45
Effect of nisin on microbiome-brain-gut axis neurochemicals by Escherichia coli -induced diarrhea in mice
Jia, Z., Chen, A., Bao, F., He, M., Gao, S., Xu, J., Zhang, X., Niu, P., & Wang, C. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.04.005 · Cited by 46
Rifaximin and diverticular disease: Position paper of the Italian Society of Gastroenterology (SIGE)
Cuomo, R., Barbara, G., & Annibale, B. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.164 · Cited by 43
Intestinal microbiota regulates the gut-thyroid axis: the new dawn of improving Hashimoto thyroiditis
Zhu, X., Zhang, C., Feng, S., He, R., & Zhang, S. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01304-4 · Cited by 52
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42

Authors: Xu, D., Gao, J., Gillilland, M., Wu, X., Song, I., Kao, J. Y., & Owyang, C.
Affiliations: University of Michigan (US)
Corresponding author: Owyang, Chung
ORCID: Gao, Jun
Gillilland, Merritt
Wu, Xiaoyin
Kao, John Y.
Owyang, Chung
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2014-02
Volume: 146
Issue: 2
Pages: 484-496.e4
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2013.10.026
PMC: PMC3939606
OpenAlex: W2125894152
Cited by: 271
References: 47
Citations by year: 2026: 12 · 2025: 17 · 2024: 15 · 2023: 26 · 2022: 21 · 2021: 30 · 2020: 11 · 2019: 22 · 2018: 27 · 2017: 30 · 2016: 24 · 2015: 21 · 2014: 15
FWCI: 18.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (P30DK34933, R01DK058913)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords: rifaximin, gut microbiota, visceral hypersensitivity, intestinal barrier function, Lactobacillus, neomycin, chronic psychological stress, water avoidance stress, occludin, intestinal permeability, rectal sensitivity, functional gastrointestinal disorders
MeSH terms: Rifaximin, Administration, Oral, Animals, DNA, Bacterial, Drug Administration Schedule, Gastrointestinal Agents, Hyperalgesia, Ileitis, Ileum, Immunohistochemistry, Intestinal Mucosa, Male, Neomycin, Restraint, Physical, Rifamycins, Stress, Psychological, Blotting, Western, Biomarkers, Cytokines, Rats, Wistar, Sequence Analysis, DNA, Reverse Transcriptase Polymerase Chain Reaction, Rats, Occludin, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks